Buzz Stocks: Apple Inc., Hologic, Inc., and JD.Com Inc

Today's stocks to watch in the news include Apple Inc. (AAPL), Hologic, Inc. (HOLX), and JD.Com Inc (ADR) (JD)

Jun 20, 2016 at 10:34 AM
facebook twitter linkedin

U.S. stocks are higher amid waning "Brexit" fearsAmong the equities in focus today are tech giant Apple Inc. (NASDAQ:AAPL), biotech stock Hologic, Inc. (NASDAQ:HOLX), and Chinese e-tailer JD.Com Inc (ADR) (NASDAQ:JD).
  • AAPL is up 1.3% at $96.52, following a mixed bag of news from the company, including: reports that it will not be providing any support to the upcoming Republican convention in light on Donald Trump's controversial comments on issues such as immigration and minorities; concerns about Apple Inc. losing its weighting in the Russell 2000 Index (RUT); and reports that AAPL could open its first stores in India, after the Indian government loosened foreign retailer requirements. AAPL is down nearly 25% year-over-year, and the shares touched a two-year low in early May, following a historic losing streak. Option traders seem increasingly wary of AAPL, with the stock's 50-day put/call volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE) and NASDAQ OMX PHLX (PHLX) of 0.72 sitting higher than 94% of all other readings from the past year. However, analysts remain optimistic towards the stock, with 25 of 30 offering up a "buy" or better position, and only one "sell" recommendation to be found. Should AAPL continue to struggle, a flood of downgrades could exacerbate selling pressure.
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial


Special Offers from Schaeffer's Trading Partners